- Home
- IMVT vs ALHC Comparison
IMVT vs ALHC Comparison
Compare IMVT & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- ALHC
- Stock Information
- Founded
- IMVT N/A
- ALHC 2013
- Country
- IMVT United States
- ALHC United States
- Employees
- IMVT N/A
- ALHC N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- ALHC Medical Specialities
- Sector
- IMVT Health Care
- ALHC Health Care
- Exchange
- IMVT Nasdaq
- ALHC Nasdaq
- Market Cap
- IMVT 3.4B
- ALHC 3.1B
- IPO Year
- IMVT N/A
- ALHC 2021
- Fundamental
- Price
- IMVT $18.37
- ALHC $18.30
- Analyst Decision
- IMVT Strong Buy
- ALHC Buy
- Analyst Count
- IMVT 11
- ALHC 11
- Target Price
- IMVT $44.13
- ALHC $15.35
- AVG Volume (30 Days)
- IMVT 1.9M
- ALHC 2.7M
- Earning Date
- IMVT 02-06-2025
- ALHC 05-01-2025
- Dividend Yield
- IMVT N/A
- ALHC N/A
- EPS Growth
- IMVT N/A
- ALHC N/A
- EPS
- IMVT N/A
- ALHC N/A
- Revenue
- IMVT N/A
- ALHC $2,703,561,000.00
- Revenue This Year
- IMVT $108.88
- ALHC $39.82
- Revenue Next Year
- IMVT N/A
- ALHC $25.16
- P/E Ratio
- IMVT N/A
- ALHC N/A
- Revenue Growth
- IMVT N/A
- ALHC 48.25
- 52 Week Low
- IMVT $17.01
- ALHC $4.46
- 52 Week High
- IMVT $34.47
- ALHC $18.35
- Technical
- Relative Strength Index (RSI)
- IMVT 42.05
- ALHC 75.70
- Support Level
- IMVT $17.49
- ALHC $17.29
- Resistance Level
- IMVT $18.96
- ALHC $17.80
- Average True Range (ATR)
- IMVT 1.23
- ALHC 0.74
- MACD
- IMVT -0.01
- ALHC 0.16
- Stochastic Oscillator
- IMVT 39.65
- ALHC 98.70
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.